UK to deliberately infect humans with COVID-19 to test potential vaccines: Reports
New Delhi, Sep 24: In a first, the UK is set to host clinical trials where healthy volunteers are deliberately infected with coronavirus to assess the effectiveness of experimental vaccines, the Financial Times reported.
The government-funded project is expected to begin in January at a quarantine facility in London.
About
2,000
potential
volunteers
have
signed
up
for
the
studies,
the
report
added.
Volunteers
who
qualify
for
the
trials
will
be
injected
with
an
experimental
vaccine
before
being
administered
a
dose
of
Sars-Cov-2,
the
virus
that
causes
Covid-19,
under
controlled
conditions.
It
did
not
name
the
vaccines
that
would
be
assessed
in
the
project.
British drugmaker AstraZeneca, and French firm Sanofi both told Reuters that their vaccine candidates were not involved in the programme.
The FT report said that the volunteers for the project, which will be announce next week, will be first inoculated with a vaccine and later receive a challenge dose of the Covid-19 causing SARS-CoV-2 coronavirus, under controlled conditions.
Recommended Video
According to the report, the challenge trials have been instrumental in developing vaccines and treatments for typhoid, cholera and malaria and in understanding how the immune system responds to flu.
Watch: MP home minister refuses to wear mask; Is it for only common man asks Cong
The project's academic leader is Imperial College London, and it will be run by hVivo, a spinout from Queen Mary University of London that was bought earlier this year by Open Orphan, a Dublin-based pharmaceutical research organisation, the report said.